Lec 19 - Bloodborne viral infections 1: HBV and HCV Flashcards

1
Q

What are the main concerns associated with hepatitis viruses?

A
  • Cause hepatitis and liver cancer with a bad prognosis
  • High risk of occupational exposure due to blood exposure and extensive survival on fomites
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Describe hepatitis viruses types A-G by transmission and result of infection.

A

A = enteral transmission and causes acute hepatitis
B = bloodborne/parenteral transmission and causes hepatocellular carcinoma
C = bloodborne/parenteral transmission and causes hepatocellular carcinoma
D = parenteral transmission; satellite virus; chronic infection when coinfection with B
E = enteral transmission and causes acute hepatitis
F and G = unknown significance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe the Baltimore classification and T value of hepatitis viruses.

A

Group 7 = dsDNA circular genome with RNA section, 4 overlapping ORFs, and RNA intermediate, T = 4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the 4 proteins of hepatitis viruses?

A
  1. S = surface protein HBsAg
  2. C = structural core protein HBcAg
  3. P = non-structural precore protein/secreted e antigen HBeAg and polymerase
  4. X protein
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe the life cycle of HBV.

A
  1. Attachment to heparin sulfate proteoglycan with low affinity and NTCP transmembrane receptor (high affinity)
  2. Clathrin mediated endocytosis
  3. Uncoating and nuclear entry as relaxed circular DNA (RC-DNA) converted to cccDNA
  4. Transcription by host RNA polymerase to pgRNA and sgRNA
  5. pgRNA packaged with P protein into nucleocapsid and reverse transcribed
  6. (+) DNA synthesised from (-) DNA strand to make RC-DNA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the reason for the short RNA section in HBV’s genome?

A

Run out of nucleotides in nucleocapsid when pgRNA reverse transcribed by viral polymerase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the function of HBV’s subviral particles (SVPs)? Describe their structure and list the 3 types.

A
  • Divert neutralising antibodies
  • Have envelope glycoproteins and host lipids in their structure but no genome
    1. Spherical SVP
    2. Filamentous SVP
    3. Dane particles
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe the transmission of HBV and list examples of how it can occur. What body secretions have the most virus?

A
  • Parenteral transmission eg transplants, transfusions, needles, vertical, intra-familial, sex
  • Most virus in blood and wound exudates, less in genital secretions and saliva, undetectable in sweat, milk and urine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What Australian population/s has the most and least HBV?

A
  • Endemic in Aboriginal and Torres Strait Islander populations especially in NT
  • Very low in Tasmania from vaccination rates
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the incubation time for HBV? List some symptoms.

A

Incubation = 45-180 days
Symptoms = flu-like, icterus/jaundice, pruritus/itching

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the 3 types of disease resulting from HBV?

A
  1. Acute = asymptomatic and cleared by host
  2. Chronic = virus replicates for 6+ months after infection in 10% of cases
  3. Fulminant = 1/1000 patients die in 10 days from immune destruction of hepatocytes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Who is most at risk of chronic HBV infection? How is it prevented?

A

Pregnant women and young children at risk. Immunoglobins and vaccinations to infants within 12hrs of birth are administered

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How can you tell the difference between recovery of HBV and chronic infection/carrier? How is HBV exposure determined?

A

Clearance = anti-HBs and/or anti-HBe
Chronic/carrier = HBsAg and high ALT with no antiHBs and/or anti-HBe
Exposure = anti-HBc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the treatment options for HBV?

A
  • Nucleoside/nucleotide analogues eg lamivudine to inhibit viral DNA rep and reduce hepatic necrosis and conversion of S antigen to HBeAg
  • Antiretrovirals for drug resistant virus
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the sign of active HBV replication?

A

HBeAg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe the structure and genome of HDV.

A

Enveloped circular (-) ssRNA genome, large and small delta antigens, S and M glycoproteins

17
Q

What are the 2 types of HDV infection with HBV? How is it prevented?

A
  1. Coinfection = severe HBV acute infection
  2. Superinfection = chronic HBV carriers with HDV infection get severe chronic HBV infection
    Prevention by HBV immunisation
18
Q

What disease does HDV infection alone cause?

A

Asymptomatic or fulminant hepatitis

19
Q

What disease does HCV cause and why is it less dangerous than HBV?

A

Causes liver cirrhosis and liver carcinoma but treatment cures 95% of HCV

20
Q

Describe the structure of HCV virus particles in blood that allows them to enter hepatocytes.

A

Spherical hybrid/heterogenous lipoviral particles

21
Q

What are the 2 most common subtypes of HCV in Australia?

A

G1 and 3 from drug injections

22
Q

Describe the genome and structure of HCV and how it enters cells.

A

(+) ssRNA genome, single ORF, transcription and translation functions, RdRp
Clathrin mediated endocytosis

23
Q

How do HCV proteins change the structure of host cells?

A

Viral proteins interact with host factors to rearrange intracellular membranes of ER = membranous web microenvironment

24
Q

How is HCV transmitted and what are the different disease progressions after what incubation time?

A
  • Parenteral transmission with blood contact and sexual transmission most common
  • 2-6 month incubation
  • 80% asymptomatic
  • 70% of infections become chronic persistent with cirrhosis in 10-20%